Atrial Fibrillation Trial, Recruiting NCT05427435 Sponsor: University Hospital, Bordeaux Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT05427435
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been assessed as suitable candidates for a catheter ablation procedure for atrial fibrillation (AF), including those with a history of symptomatic persistent AF, or those having a repeat procedure for persistent or paroxysmal AF under certain conditions (confirm with trial site)
  • People aged 18 or older, of any gender
  • People who are covered by a social security scheme (confirm with trial site)
  • People who are willing and able to sign a written consent form before any trial-related assessments begin
  • Women who could become pregnant must be using effective contraception

Who may not be able to join:

  • People under 18 years of age
  • People who have a blood clot in the left chamber of the heart, or another physical condition that would prevent the procedure from being performed
  • People for whom blood-thinning medications (such as heparin, warfarin, or similar drugs) are not medically safe to use
  • People who cannot receive the contrast dye product XENETIX® — for example, due to an allergy to its ingredients or a history of serious reactions to it, or due to a thyroid condition called thyrotoxicosis
  • People with a known sensitivity or allergy to ethanol (alcohol)
  • People currently experiencing unstable chest pain or an ongoing lack of blood supply to the heart
  • People who have had a heart attack within the 3 months before joining the trial
  • People with a heart condition present from birth that increases the risks associated with the ablation procedure
  • People with a serious disorder affecting bleeding, blood clotting, or clot formation
  • Women who are pregnant, in labour, or currently breastfeeding
  • People who are unable or unwilling to sign a written consent form
  • People who are in custody or detained under a court or administrative order
  • People currently receiving psychiatric care
  • People who are living in a care or social facility for reasons unrelated to this research
  • People who are under a legal protection arrangement such as guardianship

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nicolas MD DERVAL, Study Principal Investigator

Phone: (0)5 57 65 64 71

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 May 2022
Est. completion
16 May 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Acute success rate of the procedure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov